Omega3-fatty acid (Omacor) therapy for atrial fibrillation prevention after surgical myocardial revascularization (AXIOMA Study)

Abstract

Resume The article contains results of using щ-3 polyunsaturated fatty acids in atrial fibrillation prevention after myocardial revascularization. Increased coronary artery bypass graft surgery (CABG) rates in Russia require active implementation of methods improving short and long-term outcome. Secondary coronary artery disease prevention includes risk factors control, antiaggregant, beta-adrenoblocker, lipid-lowring and ACE inhibitor therapy. Recent studies have showed beneficial щ-3 polyunsaturated fatty acids role in improving CABG outcomes.